Tus-Guhan Group Corp Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tus-Guhan Group Corp Ltd with three other
companies in this sector in China:
Hainan Poly Pharm Co Ltd
sales of 324.83 million Chinese Renmimbi [US$50.91 million]
of which 43%
was Antiallergic drugs),
Real Nutriceutical Group Ltd
(357.66 million Chinese Renmimbi [US$56.06 million]
of which 82%
was Health and nutritional supplements), and
Shenyang Xingqi Pharmaceutical Co Ltd
(360.01 million Chinese Renmimbi [US$56.43 million]
of which 100%
was Pharmaceutical manufacturing industry).
Tus-Guhan Group Corp Ltd reported sales of 343.54 million Chinese Renmimbi (US$53.85 million)
December of 2017.
increase of 8.2%
versus 2016, when the company's sales were 317.41 million Chinese Renmimbi.
This was the third consecutive year of growth at Tus-Guhan Group Corp Ltd.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Tus-Guhan Group Corp Ltd had sales
of 362.83 million Chinese Renmimbi.
Sales of Others saw an increase
that was more than double the company's growth rate: sales were up
994.8% in 2017, from
54,843.31 Chinese Renmimbi to 600,441.68 Chinese Renmimbi.
Tus-Guhan Group Corp Ltd also saw significant increases in sales in
Pharmaceutical Wholesale and Retail (up 219.3% to 50.63 million Chinese Renmimbi)
Not all segments of Tus-Guhan Group Corp Ltd experienced an increase in sales in 2017:
sales of Western Medicine Manufacturing fell 15.4% to 16.80 million Chinese Renmimbi.
Tus-Guhan Group Corp Ltd also experienced decreases in sales in
Tcm and Tonics Manufacturing (down 2.2% to 275.51 million Chinese Renmimbi)